Peptide GAM immunoadsorption therapy in primary membranous nephropathy (PRISM): Phase II trial investigating the safety and feasibility of peptide GAM immunoadsorption in anti-PLA [electronic resource]

By: Contributor(s): Producer: 20181109Description: 283-290 p. digitalISSN:
  • 1098-1101
Subject(s): Online resources: In: Journal of clinical apheresis vol. 33
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

There are no comments on this title.

to post a comment.